Publications by authors named "Mary Strange"

Claim this Profile
M
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer.
Lixin Zhang, Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange

Dis Model Mech· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites.
Lixin Zhang, Mary Strange, Esther Elishaev, Syed Zaidi, Francesmary Modugno

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy.
Adria Suarez Mora, Mary Strange, Yusi Fang, Ibrahim Uygun, Lixin Zhang

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.
Brian Orr, Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Shannon Grabosch, George Tseng, Robert P Edwards, Heather A Lankes, Kathleen Moore, Mary Strange

Gynecol Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma.
Ashlee L Smith, Mai Sun, Rohit Bhargava, Nicolas A Stewart, Melanie S Flint, Mary A Strange

Proteomes· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.
Julie A Deloia, Nikhil R Bhagwat, Kathleen M Darcy, Mary Strange, Chunquio Tian

Gynecol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.
Diana L Kolbe, Julie A DeLoia, Patricia Porter-Gill, Mary Strange, Hanna M Petrykowska

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Cathy B Wilcox, Bora E Baysal, Holly H Gallion, Mary A Strange, Julie A DeLoia

Cancer Genet Cytogenet· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis